InvestorsObserver is giving ORIC Pharmaceuticals Inc (ORIC) an Analyst Rating Rank of 30, meaning ORIC is ranked higher by analysts than 30% of stocks. The average price target for ORIC is $13.666 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ORIC a Buy today. Find out what this means to you and get the rest of the rankings on ORIC!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With ORIC Pharmaceuticals Inc Stock Today?
ORIC Pharmaceuticals Inc (ORIC) stock is up 13.72% while the S&P 500 is down -1.49% as of 1:21 PM on Friday, Jun 3. ORIC has risen $0.45 from the previous closing price of $3.28 on volume of 132,843 shares. Over the past year the S&P 500 is lower by -1.87% while ORIC is down -81.69%. ORIC lost -$2.21 per share the over the last 12 months.
Click Here to get the full Stock Report for ORIC Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
